$400,000

Due: 2023-12-01

Summary: The Food and Drug Administration's (FDA) Center for Tobacco Products (CTP) is inviting applications for projects dedicated to the development of data standards and terminologies for tobacco research. This initiative, titled "Data Standards for Tobacco Research and Scientific Review Phase 2," aims to uphold the quality of tobacco research while also… Read More

$750,000

Due: Applications Ongoing

Summary: The National Science Foundation (NSF) and the U.S. Food and Drug Administration (FDA) have joined forces to create the NSF/FDA Scholar-in-Residence Program at FDA. This collaboration aims to explore scientific and engineering issues around emerging technologies in the medical device sector. It provides a platform for scholars in science, engineering,… Read More

$500,000

Due: 2024-02-02

Summary: The Minor Use Minor Species Development of Drugs (R01) is a grant opportunity released by the Food and Drug Administration's Center for Veterinary Medicine (CVM). They are inviting research projects from institutions or organizations committed to developing or supporting new animal drugs designed for minor uses in major species or use in minor species,… Read More

Funding Varies

Due: 2024-04-05

Summary: This is a notification about the PHS 2023-2 Omnibus Solicitation; a funding opportunity for Small Business Innovation Research Grants (SBIR), announced by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA). The government bodies involved in this solicitation are… Read More

Funding Varies

Due: 2023-12-06

Summary: This funding opportunity announcement (FOA) is aimed at bolstering the development of Digital Therapeutics (DTx) for treating Substance Use Disorders (SUDs). The unprecedented advancement of technology has opened up avenues to create clinical-grade platforms that are mobile, web, or software-based, which can provide safe and effective treatments for… Read More

Funding Varies

Due: 2025-01-07

Summary: This grant opportunity is focused on the development of next-generation neuromodulation or neurostimulation devices intended to treat various mental health disorders. The grant, a reissue of PAR-18-942, does not allow for clinical trials. Applications are welcomed from individuals or groups who aim to either create innovative brain stimulation devices… Read More

Funding Varies

Due: 2025-05-04

Summary: This is an announcement about a grant opportunity called the Tobacco Regulatory Science (R01 Clinical Trial Optional). Its goal is to fund both behavioral and biomedical research that will yield scientific data, aiding in the regulation of tobacco products for the sake of public health. Applicants are asked to design Research Projects that focus on… Read More

Funding Varies

Due: 2023-12-06

Summary: The Public Health Communication Messaging about the Continuum of Risk for Tobacco Products grant is inviting applications for a research project. This important project, which requires a clinical trial, aims to utilize health communication research to better understand the potential impact of messaging surround the risks of tobacco products on different… Read More

Funding Varies

Due: 2025-01-07

Summary: This is a grant offered for the development of Neuromodulation/Neurostimulation devices, specifically designed for mental health applications. It's a reissue of the previous grant known as PAR-18-941. The grant's main goal is to encourage researchers and developers to create innovative brain stimulation devices aimed at treating mental health disorders.… Read More

Funding Varies

Due: 2026-12-04

Summary: This text is about a Notice of Funding Opportunity (NOFO) called the Planning for Product Development Strategy (R34 Clinical Trial Not Allowed). Its goal is to offer financial support to help create detailed and comprehensive plans regarding the development of new treatments for HIV and related comorbidities, coinfections, and complications. The funding… Read More

Funding Varies

Due: 2026-10-27

Summary: The National Institute on Deafness and Other Communication Disorders (NIDCD) has a cooperative agreement known as "Clinical Trials in Communication Disorders" (U01 - Clinical Trial Required). The main goal of this funding opportunity announcement (FOA) is to support the identification of effective treatments or prevention strategies for communication… Read More

Funding Varies

Due: 2025-03-16

Summary: The National Eye Institute has established the Translational Research Program for Therapeutics. This grant program aims to quickly and efficiently transfer the outcomes of innovative lab research into practical treatments for visual diseases or disorders. This work is to be performed by multi-disciplinary teams of scientists and clinicians who will… Read More

Funding Varies

Due: 2025-03-16

Summary: The National Eye Institute (NEI) is currently offering a grant dedicated to the conversion of innovative research findings into medicine for visual system diseases or disorders, known as the Translational Research Program for Therapeutics. However, this grant does not include clinical trials (referenced as R33). The aim of this grant is to speed up… Read More

Funding Varies

Due: 2024-12-04

Summary: This grant opportunity is aimed at small businesses, including those owned by women and other disadvantaged groups, that are developing medicinal treatments for alcohol use disorder (AUD) or associated organ damage (AAOD). In order to qualify, applicants should already have a candidate therapeutic agent with significant supporting data from early discovery… Read More